Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

How we helped to enrich the understanding of value message trade-off choices made by payers in the psoriasis market

How we helped to enrich the understanding of value message trade-off choices made by payers in the psoriasis market

Our client’s global market access team was preparing value message themes and statements for their new Psoriasis treatment. In order to help prepare them for a successful competitive launch, research was required to better understand the strength and resonance of those statements and themes with payers and to identify the best language and prioritisation for each payer archetype.

read more »

  • Posted by George Forsyth
  • July 27, 2020
  • Articles

How will COVID-19 affect the financing of healthcare provision across the US?

How will COVID-19 affect the financing of healthcare provision across the US?

Using findings from our syndicated study to assess the impact of COVID-19 on biopharmaceutical market access, Senior Consultant George Forsyth explores the economic impact to the US healthcare system. Published by Pharma Exec in June 2020.

The current coronavirus pandemic sweeping across the globe represents one of the greatest fiscal challenges to US healthcare policymakers in modern times. The Federal Reserve expects the US economy to contract by a staggering 6.5% this year, with approximately 20 million Americans unemployed and many more without medical insurance. 

read more »

How we assessed the access potential of a new product in order to develop a successful launch strategy

How we assessed the access potential of a new product in order to develop a successful launch strategy

Our client had two regimens in clinical development for the front-line treatment of an oncology condition using a breakthrough product; and planned to release outcomes data at key industry events throughout the year.

To ensure a fast and successful launch they wanted to develop key strategies to maximise acceptance and reimbursement of their product amongst HCPs and Payers. 

read more »

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market

Our client had their product  for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering strategies to manage combination therapies in the future. Therefore, they wanted to understand what the current and future combination pricing strategies were for oncology products, with a focus on MM and their product.

read more »

How we helped assess the asthma market landscape in emerging markets

How we helped assess the asthma market landscape in emerging markets

Our client was jointly developing a fully-human monoclonal antibody (mAB) with a number of potential immunological indications. In order to prepare for launch, primary and secondary market research was required to understand more fully the asthma landscape.

read more »